Institutional
July 27, 2017
São Paulo Court allows the marketing of generic drug while the patent applications for the reference drug are still pending
Allergan had obtained an injunction preventing the marketing of a generic drug for Combingan®. However, such injunction was revoked because the Trial Court understood in a decision on the merits the owner of pending patent applications does not enjoy exclusive rights. The decision may be subject to an appeal.
Click on Download to access the full text of the decision.
Back
Share:
Last related news
November 8, 2021
Meet our new visual identity!
For over one hundred years, we have believed in all types of innovation, from market trends and new client products and services … Meet our new visual identity!
June 29, 2021
Kasznar Leonardos donates basic foodstuffs to families in Rio de Janeiro and Sao Paulo
As part of its Social Responsibility Program, Kasznar Leonardos donated over 700 packages of basic foodstuffs through the “Gramachinhos” Project in Rio … Kasznar Leonardos donates basic foodstuffs to families in Rio de Janeiro and Sao Paulo
May 26, 2021
Kasznar Leonardos celebrates the first year of its Diversity & Inclusion Program
In May 2020, Kasznar Leonardos implemented its Diversity and Inclusion Program aiming to create a more inclusive work environment. Over the past … Kasznar Leonardos celebrates the first year of its Diversity & Inclusion Program